PACB icon

Pacific Biosciences
PACB

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$2
14% downside
High target

2 analyst ratings

positive
1  neutral
50%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Piper Sandler
Piper Sandler
David Westenberg
11 Nov ‘25 19 days ago
Stephens & Co
Stephens & Co
Mason Carrico
75% 1-yr PACB win rate
10 Nov ‘25 20 days ago